全球處方藥行業(yè)市場前景及投資研究報(bào)告-培訓(xùn)課件外文版2024.5片仔癀

INDUSTRIES

&

MARKETSPrescription

Drugs:

market

data&

analysisMarket

InsightsreportOctober2023Table

of

ContentsOverviewAppendixSummary567ProductOverviewAuthor1920MarketDefinitionKeyTakeawaysMarket

NumbersRevenue

by

Market91215AverageRevenue

per

CapitaAverageRevenue

per

Pharmacy2MARKET

INSIGHTSThis

report

is

part

ofour

Market

Insights

productGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.?

10

sectors:

advertising&media,consumers,countries,digital

sector,finance,health,

industrialsector,mobility,andtechnology?

1,000+

markets,

e.g.,

FinTech,Food,or

Robotics?

KPIs,

e.g.,

revenue,marketshares,prices,andvolume?

Features:Compare

countries®ions,

change

currencies,

selectvisualizations,

and/or

customize

downloads?

Usecases:

sales

planning,

investment

decision

support,resourceallocation,andportfolio

management10sectors190+geographicalentities1,000+markets400+reportsFind

out

more

on:https://www.Goto

Market

Insightscom/outlook/3CHAPTER

1OverviewThe

Prescription

Drugs

market

is

a

steadily

growing

marketOverview:

SummarySummaryThePharmacies

market

generated

aglobal

revenue

of

US$1.2

trillion

in2021

andisexperiencing

steadygrowth,

primarily

dueto

therisingdemand

forhealthcareproducts

and

theincreasing

role

ofonline

pharmacies

inthehealthcare

system.TheOTCProductsmarket

is

growing

fasterthan

thePrescription

Drugsmarket;however,

with

a25%

shareof

thetotalPharmacies

market

turnover,

OTCproducts

playamuchsmaller

role

than

prescription

drugs,which

stand

at75%.maintainingthehealthcare

system,

aspeople

increasingly

turnedtopharmacieswith

theirhealthproblems.

Asaresult,thePharmacies

market

suffered

onlyslightdeclines

ingrowth

in2020,

which

were

much

smaller

thanthoseexperienced

byhospitals,forexample.

With2.25%,

itsglobal

growth

was

stillwellinpositive

territory.

In2021,

meanwhile,

thePharmacies

market

already

sawstrong

growth

again,with

a6.88%

rise,

anditcanbeassumed

thatpharmacieswill

continue

to

bethemost

frequent

pointof

contactinhealthcare

inthecomingyears.

Fear

ofinfection

andmeasures

suchasquarantineandcontactbansduringthepandemic

haveled

toanincrease

inthenumberofonline

customers,strongly

reinforcing

thetrend

thatmore

and

more

pharmacies

are

establishing

anonlinesales

channel.Althoughmanyconsumers

stillprefer

physicalpharmacies,

theshoppingexperience

is

beingsignificantlychanged

byadvancingdigitalization.

Differentcustomer

journeys

are

emerging

with

various

touchpointsbetween

the

customerandthepharmacy.

These

canbedividedintothreemain

groups:

theentirebuyingprocess

takesplaceinthephysicalpharmacy,customers

order

productsonlineandpickthemuponsite,or

customers

order

products

online

and

havethemdelivered

totheirhomes.DuringtheCOVID-19

pandemic,pharmacies

haveplayedanimportant

role

in5Sources:Market

Insights

2023The

Prescription

Drugs

market

is

an

important

part

of

the

Pharmacies

marketOverview:

Market

DefinitionMarket

definitionThePrescription

Drugsmarket

includespharmaceuticals

and

other

medicalproducts

thataresold

inpharmacies

andareonly

availableon

prescription.Additionalinformation:Themarket

comprises

revenue

andrevenue

growth.

Revenues

are

generatedthroughoffline

and

onlinespending

by(B2C)

consumers

and

includeVAT.Formore

information

on

the

datadisplayed,usetheinfobuttonnexttotheboxes.6Sources:Market

Insights

2023Prescription

Drugs

accounted

for

75%

of

the

Pharmacies

market

revenue

in2022Overview:

Key

Takeaways

and

inscope

/outof

scopeKeyTakeawaysInscopeOutof

scopeRevenue

inthePrescription

Drugsmarket

isprojected

toreach

US$71.98bn

in2023.Thismarket

includes:Thismarket

excludes:Revenue

is

expected

toshow

anannualgrowth

rate(CAGR(1)

2023-2028)

of

1.89%,resulting

inamarket

volume

of

US$79.03bn

by2028.?Prescription

pharmaceuticals?Prescription

medical

products?OTC

pharmaceuticals?OTC

medical

products?Pharmacy-usual

itemsInglobalcomparison,

most

revenue

will

begenerated

in

theUnitedStates(US$344.10bn

in2023).Inrelation

to

totalpopulation

figures,per

person

revenues

of

US$0.58k

aregenerated

in2023.7Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:CHAPTER

2Market

NumbersPrescription

Drugs

revenue

is

estimated

to

increase

with

a

CAGR(1)

of

4.2%

from2016

to

2028Market

Size:

GlobalRevenue

forecast

inbillionUS$1,278.11,229.8+4.2%(1)1,181.51,133.21,084.91,036.6990.6934.0872.5857.1839.6806.7782.620162017201820192020202120222023202420252026202720289Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:With

a

revenue

of

US$

420.9

billion,

the

Americas

is

the

biggest

market

amongselected

regions

in

2022Market

Size:

Regional

Comparison

(1/2)Revenue

forecast

inbillionUS$+4.1%(1)536.8+5.3%(1)420.9+3.5%(1)312.7394.1289.1254.0+4.1%(1)+4.7%(1)12.115.414.519.22022202820222028202220282022202820222028EuropeAfricaAmericasAsiaAustralia&Oceania10

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

a

revenue

of

US$

330.3

billion,

the

United

States

is

the

biggest

marketamong

selected

countries

in

2022Market

Size:

Regional

Comparison

(2/2)Revenue

forecast

inbillionUS$+4.0%(1)418.4330.3+6.9%(1)203.3+1.8%(1)+4.4%(1)136.12022+2.5%(1)79.078.870.960.947.240.8202220282028202220282022202820222028United

StatesChinaJapanGermanyFrance11

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023The

average

revenue

percapita

for

Prescription

Drugs

is

estimated

to

increasefrom2016

to

2028Market

Size:

GlobalAverageSpendperCapita

forecast159.80154.9016014012010080150.00145.00140.00134.90129.90123.40116.30115.30114.00110.80108.606040200201620172018201920202021202220232024202520262027202812

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023The

Americas

has

the

biggest

value

for

Prescription

Drugs

average

revenue

percapita

in

2028Market

Size:

Regional

Comparison

(1/2)AverageSpendperCapita

forecast55050045040035030025020015010050515.11499.27483.31467.20450.92434.48419.14394.67422.50371.00377.97378.19409.69359.20363.96360.00396.65347.40347.90331.74383.36335.60369.82323.90355.99312.30342.73300.60334.14261.50327.77289.80320.92276.50296.66262.70294.43267.50260.6084.7510.87202878.0410.5381.4110.7148.269.9071.2310.1474.6510.3449.609.4252.0364.409.7467.799.9360.389.3954.419.2755.928.799.450201620172018201920202021202220232024Asia202520262027AmericasAustralia&OceaniaEuropeAfrica13

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

US$

976.53,

the

United

States

has

the

highest

average

revenue

per

capitaamong

selected

countries

in

2022Market

Size:

Regional

Comparison

(2/2)AverageSpendperCapita

forecast1,199.451,162.541,125.361,087.891,2001,0008001,050.121,012.04976.53917.65883.11890.27826.86630.20798.04611.53

609.25777.77722.92707.09691.25675.41659.56643.69630.80602.61597.33659.03949.33643.58913.04571.72549.22628.34876.94613.30841.02598.45583.80571.98554.82540.86600

523.34498.32579.07496.28636.50805.27769.66718.15730.93400

566.82597.73635.432000142.43126.43134.41110.61118.5094.972022102.7587.41202176.6661.71201768.66201871.38201957.882016202020232024Japan2025China202620272028United

StatesFranceGermany14

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023The

average

revenue

per

pharmacy

for

Prescription

Drugs

is

estimated

toincrease

from

2016

to

2028Market

Size:

GlobalAverageSpendperPharmacy

forecast

inmillion0.550.520.500.480.500.450.400.350.300.250.200.150.100.050.000.460.440.420.400.380.360.350.350.330.33201620172018201920202021202220232024202520262027202815

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Australia

&

Oceania

has

the

biggest

valuefor

Prescription

Drugs

averagerevenue

per

pharmacy

in

2028Market

Size:

Regional

Comparison

(1/2)AverageSpendperPharmacy

forecast

inmillion2.01.851.781.701.631.441.551.381.481.321.621.561.411.260.871.51.00.50.01.501.331.180.841.281.261.251.171.111.181.131.071.031.001.060.800.971.040.760.941.000.760.900.780.760.120.120.210.160.220.160.230.170.130.1320170.130.130.180.140.190.150.200.150.170.140.140.130.140.120.160.13201620182019202020212022Americas20232024Asia2025Africa202620272028Australia&OceaniaEurope16

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

US$

3.73

million,

the

United

States

has

the

highest

average

revenue

perpharmacy

among

selected

countries

in

2022Market

Size:

Regional

Comparison

(2/2)AverageSpendperPharmacy

forecast

inmillion4.694.524.405.04.364.194.204.044.614.53.883.733.494.03.393.343.983.123.773.013.5

2.923.03.573.343.242.822.722.612.52.421.821.072.331.832.182.131.222.081.212.01.51.00.50.02.031.191.981.171.931.161.881.051.891.151.791.161.801.101.711.131.241.130.420.440.370.400.330.350.280.300.230.250.190.200.222016201720182019202020212022202320242025202620272028United

StatesGermanyFranceJapanChina17

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023CHAPTER

3AppendixMARKET

INSIGHTSMarket

Insights

–

market

data,forecasts,

and

qualitative

insightsGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,regional,country,

and/orstatelevel.Access

ourdatavia

web

interface,

download(XLS,

PDF,PPT),

orreports.Benefitfromour

48-hour

customerservice

gua